T-cell receptor peptides as immunotherapy for autoimmune disease

Critical Reviews in Immunology

Volumn 17, Issue 5-6, 1997, Pages 507-510

  Gold, Daniel P ^a   Shroeder, Kim ^b   Golding, Anna ^a   Brostoff, Steven W ^c   Wilson, Darcy B ^b  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c Orchestra Therapeutics Inc   (United States)

Author keywords

Immunoregulation; Multiple sclerosis; Vaccines

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MYELIN BASIC PROTEIN; RECEPTOR PROTEIN; T LYMPHOCYTE RECEPTOR; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; AUTOIMMUNITY; CONFERENCE PAPER; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTHERAPY; MICE; PEPTIDES; RATS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0030712298     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Martenson, R. E., Myelin basic protein speciation, in Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis, Alvord, E. C., Jr., Kies, M. W., and Suckling, A. J., Eds., Alan R. Liss, New York, 1984, 146-511.
2. Chou, Y. K., Vandenbark, A. A., Jones, R. E., Hashim, G., and Offner, H., Selection of encepha litogenic rat T-lymphocyte clones recognizing an immunodominant epitope of myelin basic protein, J. Neurosci. Res., 22, 181-187, 1989.
3. Welch, A. M., Holda, J. H., and Swanborg, R. H., Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease, J. Immunol., 125, 186-191, 1980.
4. Ben-Nun, A., Wekerle, H., and Cohen, I., The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis, Eur. J. Immunol., 11, 195-199, 1981.
5. Ben-Nun, A. and Cohen, I., Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines and characterization of the cells, J. Immunol., 129, 303-308, 1981.
6. Ben-Nun, A., Wekerle, H., and Cohen, I., Vaccination against autoimmune encephalomyelitis with T-lymphocyte lines reactive against myelin basic protein, Nature, 292, 60-61, 1981.
7. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A., and Cohen, I., Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis, Science, 239, 181-183, 1988.
8. Chluba, J., Steeg, C., Becker, A., Wekerle, H., and Epplen, J. T., T cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes, Eur. J. Immunol., 19, 279-284, 1989.
9. Burns, F. R., Li, X., Shen, N., Offner, H., Chou, Y. K., Vandenbark, A., and Heber-Katz, E., Both rat and mouse T cell receptors specific for the encepha-litogenic determinant of myelin basic protein use similar Vα and Vα chain genes even though the major histocompatibility complex and encephalito-genic determinants being recognized are different, J. Exp. Med., 169, 27-39, 1990.
10. Gold, D. P., Offner, H., Sun, D., Wiley, S., Vandenbark, A. A., and Wilson, D. B., Analysis of T cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: conserved CDR3 regions, J. Exp. Med., 174, 1467-1476, 1991.
11. Vandenbark, A. A., Hashim, G., and Offner, H., Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis, Nature, 341, 541-544, 1989.
12. Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J., and Brostoff, S. W., Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides, Science, 246, 668-670, 1989.
13. Offner, H., Vainien, M., Gold, D. P., Celnik, B., Wang, R., Hashim, G. A., and Vandenbark, A. A., Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. TCR peptide regulation of T cell clones expressing cross-reactive Vβ genes, J. Immunol., 148, 1706-1711, 1992.
14. + cells in T cell receptor peptide-induced clonal unresponsiveness, Science, 259, 91-94, 1993.
15. Kuhrober, A., Schrimbeck, R., and Reimann, J., Vaccination with T cell receptor peptides primes antireceptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL, Eur. J. Immunol., 24, 1172-1180, 1994.
16. Broeren, C. P. M., Lucassen, M. A., van Stipdonk, M. J. B., van der Zee, R., Boog, C. J. P., Kusters, J. G., and van Eden, W., CDR1 T-cell receptor β-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions, Proc. Natl. Acad. Sci. U.S.A., 91, 5997-6001, 1994.
17. Kumar, V. and Sercarz, E., Immundominant framework region 3 peptide from TCR Vβ8.2 chain controls murine experimental autoimmune encephalomyelitis, J. Immunol., 154, 1941-1950, 1995.
18. Haqqi, T. M., Qu, X., Anthony, D., Ma, J., and Sy, M., Immunization with T cell receptor Vβ chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice, J. Clin. Invest., 97, 2849-2858, 1996.
19. Moreland, L. W., Heck L. W., Jr., Koopman, W. J., et. al., Vβ17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study, J. Rheumatol., 23, 1353-1362, 1996.
20. Vandenbark, A. A., Chou, Y. K., Whitham, R., et al., Treatment of multiple sclerosis with T-cell receptor peptides: results of a double blind pilot trial, Nature Med., 2, 1109-1115, 1996.
21. Gold, D. P., Smith, R. A., Golding, A. B., Morgan, E. E., Dafashy, T., Nelson, J., Diveley, J., Laxer, J. A., Richieri, S. P., Carlo, D. J., Brostoff, S. W., and Wilson, D. B., Results of a phase I clinical trial of a T cell receptor peptide vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T cell populations before and after vaccination with a TCRVβ6 CDR2 peptide, J. Neuroimmunol., 76, 29-38, 1997.
22. Gold, D. P., TCR V gene usage in autoimmunity, Curr. Opin. Immunol., 6, 907-912, 1994.
23. Offner, H., Buenafe, A. C., Vainiene, M., Celnick, B., Weinberg, A., Gold, D. P., Hashim, G., and Vandenbark, A. A., Where, when, and how to detect biased expression of disease-relevant Vβ genes in rats with experimental autoimmune encephalomyelitis, J. Immunol., 151, 506-517, 1993.
24. Wilson, D. B., Golding, A. B., Smith, R. A., Dafashy, T., Nelson, J., Smith, L., Carlo, D. J., Brostoff, S. W., and Gold, D. P., Results of a phase I clinical trial of a T cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T cell receptor utilization in CSF cell population, J. Neuroimmunol., 76, 15-28, 1997.